With over 1.34 million Cronos Group Inc. (CRON) shares trading Monday and a closing price of $1.98 on the day, the dollar volume was approximately $2.66 million. The shares have shown a negative half year performance of -32.88% and its price on 05/22/23 gained nearly 3.66%. Currently, there are 380.63M common shares owned by the public and among those 198.58M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 12 analysts who have offered their price forecasts for CRON have a consensus price objective of $2.57. The analysts have set the share’s price value over the next 12 months at a high of $3.71 and a low of $1.80. But an upside of 46.63% will see the stock hit the forecast high price target while median target price for the stock is $2.34.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The top 3 mutual fund holders in Cronos Group Inc. are ETFMG Alternative Harvest ETF, Horizons Marijuana Life Sciences, and Vanguard Total International Stoc. ETFMG Alternative Harvest ETF owns 5.63 million shares of the company’s stock, all valued at over $10.53 million. Horizons Marijuana Life Sciences sold 69972.0 shares to see its total holdings shrink to 4.53 million shares valued at over $8.47 million and representing 1.19% of the shares outstanding. Vanguard Total International Stoc sold 50928.0 shares to bring its total holdings to over 2.58 million shares at a value of $4.82 million. Vanguard Total International Stoc now owns shares totaling to 0.68% of the shares outstanding.
Shares of Cronos Group Inc. (NASDAQ: CRON) opened at $1.90, down -$0.01 from a prior closing price of $1.91. However, the script later moved the day high at 2.0300, up 3.66%. The company’s stock has a 5-day price change of 12.50% and -9.59% over the past three months. CRON shares are trading -22.05% year to date (YTD), with the 12-month market performance down to -42.11% lower. It has a 12-month low price of $1.66 and touched a high of $3.62 over the same period. CRON has an average intraday trading volume of 1.50 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 7.84%, 5.16%, and -22.87% respectively.
Institutional ownership of Cronos Group Inc. (NASDAQ: CRON) shares accounts for 11.30% of the company’s 380.63M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $975.07M and a beta (3y monthly) value of 1.43. The earnings-per-share (ttm) stands at -$0.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.83% over the week and 4.75% over the month.
Analysts forecast that Cronos Group Inc. (CRON) will achieve an EPS of -$0.03 for the current quarter, -$0.03 for the next quarter and -$0.1 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.04 while analysts give the company a high EPS estimate of -$0.02. Comparatively, EPS for the current quarter was -$0.05 a year ago. Earnings per share for the fiscal year are expected to increase by 58.10%, and 28.60% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 12 brokerage firm advisors rate Cronos Group Inc. (CRON) as a “Moderate Buy” at a consensus score of 2.60. Specifically, 3 Wall Street analysts polled rate the stock as a buy, while 6 of the 12 advise that investors “hold,” and 0 rated it as a “Sell.”
Leave a Reply